These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3329779)
1. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Scott HV; Rieckmann KH; O'Sullivan WJ Trans R Soc Trop Med Hyg; 1987; 81(5):715-21. PubMed ID: 3329779 [TBL] [Abstract][Full Text] [Related]
2. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI Biochem Pharmacol; 1997 Apr; 53(7):943-50. PubMed ID: 9174107 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates. Edstein MD; Yeo AE; Shanks GD; Rieckmann KH Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963 [TBL] [Abstract][Full Text] [Related]
4. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro. Yeo AE; Rieckmann KH Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018 [TBL] [Abstract][Full Text] [Related]
5. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs. Winstanley PA; Mberu EK; Szwandt IS; Breckenridge AM; Watkins WM Antimicrob Agents Chemother; 1995 Apr; 39(4):948-52. PubMed ID: 7786001 [TBL] [Abstract][Full Text] [Related]
6. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase. Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254 [TBL] [Abstract][Full Text] [Related]
8. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture. Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425 [TBL] [Abstract][Full Text] [Related]
9. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains]. Basco LK; Le Bras J Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260 [TBL] [Abstract][Full Text] [Related]
10. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Fidock DA; Wellems TE Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro. Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574 [TBL] [Abstract][Full Text] [Related]
12. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions]. Ndounga M; Basco LK; Ringwald P Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466 [TBL] [Abstract][Full Text] [Related]
13. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. Sixsmith DG; Watkins WM; Chulay JD; Spencer HC Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738 [TBL] [Abstract][Full Text] [Related]
14. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials. Nduati E; Hunt S; Kamau EM; Nzila A Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035 [TBL] [Abstract][Full Text] [Related]
15. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Edstein MD; Veenendaal JR; Rieckmann KH Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899 [TBL] [Abstract][Full Text] [Related]
16. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653 [TBL] [Abstract][Full Text] [Related]
17. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum. Childs GE; Lambros C Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157 [TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of Plasmodium falciparum by pyrazofurin, an inhibitor of pyrimidine biosynthesis de novo. Scott HV; Gero AM; O'Sullivan WJ Mol Biochem Parasitol; 1986 Jan; 18(1):3-15. PubMed ID: 3515174 [TBL] [Abstract][Full Text] [Related]
19. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Foote SJ; Galatis D; Cowman AF Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221 [TBL] [Abstract][Full Text] [Related]
20. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]